Lea Wagmann

1.0k total citations
69 papers, 749 citations indexed

About

Lea Wagmann is a scholar working on Toxicology, Molecular Biology and Clinical Psychology. According to data from OpenAlex, Lea Wagmann has authored 69 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Toxicology, 18 papers in Molecular Biology and 16 papers in Clinical Psychology. Recurrent topics in Lea Wagmann's work include Forensic Toxicology and Drug Analysis (29 papers), Psychedelics and Drug Studies (16 papers) and Metabolomics and Mass Spectrometry Studies (13 papers). Lea Wagmann is often cited by papers focused on Forensic Toxicology and Drug Analysis (29 papers), Psychedelics and Drug Studies (16 papers) and Metabolomics and Mass Spectrometry Studies (13 papers). Lea Wagmann collaborates with scholars based in Germany, United Kingdom and United States. Lea Wagmann's co-authors include Markus R. Meyer, Hans H. Maurer, Sascha K. Manier, Simon D. Brandt, Veit Flockerzi, Lilian H.J. Richter, Folker Westphal, Alexander Stratford, Rolf Müller and Armin Weber and has published in prestigious journals such as Scientific Reports, Hypertension and Journal of Chromatography A.

In The Last Decade

Lea Wagmann

60 papers receiving 728 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lea Wagmann 358 233 220 196 113 69 749
Julian A. Michely 303 0.8× 219 0.9× 150 0.7× 142 0.7× 64 0.6× 15 633
Yan Shi 334 0.9× 267 1.1× 113 0.5× 76 0.4× 73 0.6× 76 796
Andreas G. Helfer 268 0.7× 202 0.9× 126 0.6× 113 0.6× 57 0.5× 20 679
Giselher Fritschi 611 1.7× 138 0.6× 264 1.2× 219 1.1× 156 1.4× 23 856
Lilian H.J. Richter 262 0.7× 108 0.5× 135 0.6× 142 0.7× 99 0.9× 16 413
Denis S. Theobald 336 0.9× 67 0.3× 164 0.7× 192 1.0× 109 1.0× 15 529
Moon Kyo In 411 1.1× 141 0.6× 99 0.5× 89 0.5× 160 1.4× 47 752
Douwe de Boer 305 0.9× 70 0.3× 180 0.8× 170 0.9× 130 1.2× 24 573
Camilla Montesano 485 1.4× 271 1.2× 96 0.4× 113 0.6× 214 1.9× 62 1.1k
Tim Sobolevsky 350 1.0× 165 0.7× 72 0.3× 87 0.4× 288 2.5× 31 827

Countries citing papers authored by Lea Wagmann

Since Specialization
Citations

This map shows the geographic impact of Lea Wagmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Wagmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Wagmann more than expected).

Fields of papers citing papers by Lea Wagmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea Wagmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Wagmann. The network helps show where Lea Wagmann may publish in the future.

Co-authorship network of co-authors of Lea Wagmann

This figure shows the co-authorship network connecting the top 25 collaborators of Lea Wagmann. A scholar is included among the top collaborators of Lea Wagmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea Wagmann. Lea Wagmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hohl, Mathias, Felix Götzinger, S. Jäger, et al.. (2025). Assessing phototoxic drug properties of hydrochlorothiazide using human skin biopsies. Communications Biology. 8(1). 705–705.
2.
Kunz, Michael, Lea Wagmann, Michael Schuster, et al.. (2025). Unveiling Cardiac Complications: A Case of Amisulpride Overdose Leading to Bradycardia, QT-Prolongation, and Torsade de Pointes Tachycardia. Therapeutic Drug Monitoring. 47(4). 462–465.
3.
4.
Fecher‐Trost, Claudia, Martin Jung, Michael F. Cole, et al.. (2025). Polyclonal antibodies towards abrin and ricin—design and potential application for mass spectrometry-based analysis of human biosamples. Archives of Toxicology. 99(11). 4399–4410.
5.
6.
Fecher‐Trost, Claudia, et al.. (2024). Rapid analysis of amatoxins in human urine by means of affinity column chromatography and liquid chromatography-high-resolution tandem mass spectrometry. Scientific Reports. 14(1). 21397–21397. 2 indexed citations
7.
Kunz, Michael, et al.. (2024). Studying drug excretion into exhaled breath aerosol – A workflow based on an impaction sampling device and LC-HRMS/MS analysis. Analytica Chimica Acta. 1323. 342991–342991. 3 indexed citations
8.
9.
Hohl, Mathias, Lucas Lauder, Lea Wagmann, et al.. (2023). Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats. Hypertension. 80(6). e90–e100. 4 indexed citations
10.
Wagmann, Lea, et al.. (2023). Sample Matrices for Mass Spectrometry–Based Adherence Monitoring: A Systematic Critical Review. Therapeutic Drug Monitoring. 46(1). 6–15. 1 indexed citations
11.
Wagmann, Lea, et al.. (2022). New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?. Therapeutic Drug Monitoring. 44(5). 599–605. 6 indexed citations
12.
Wagmann, Lea, et al.. (2022). Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases. Archives of Toxicology. 96(10). 2755–2766. 5 indexed citations
13.
14.
15.
16.
17.
Manier, Sascha K., Lea Wagmann, Veit Flockerzi, & Markus R. Meyer. (2020). Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts. Archives of Toxicology. 94(6). 2047–2059. 20 indexed citations
18.
Wagmann, Lea, Lilian H.J. Richter, Madeleine Pettersson Bergstrand, et al.. (2019). In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. Analytical and Bioanalytical Chemistry. 411(19). 4751–4763. 46 indexed citations
19.
Wagmann, Lea & Hans H. Maurer. (2018). Bioanalytical Methods for New Psychoactive Substances. Handbook of experimental pharmacology. 252. 413–439. 40 indexed citations
20.
Wagmann, Lea, Simon D. Brandt, Pierce V. Kavanagh, Hans H. Maurer, & Markus R. Meyer. (2017). In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks. Toxicology Letters. 272. 84–93. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian A. Michely Breakdown of academic impact, for papers by Yan Shi Breakdown of academic impact, for papers by Andreas G. Helfer Breakdown of academic impact, for papers by Giselher Fritschi Breakdown of academic impact, for papers by Lilian H.J. Richter Breakdown of academic impact, for papers by Denis S. Theobald Breakdown of academic impact, for papers by Moon Kyo In Breakdown of academic impact, for papers by Douwe de Boer Breakdown of academic impact, for papers by Camilla Montesano Breakdown of academic impact, for papers by Tim Sobolevsky
Rankless by CCL
2026